CLINICAL_TRIALS
trial_result
· 2022-05-06
Clinical Trial Update: Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children [Phase 1, Phase 2]
Summary
A completed Phase 1/2 clinical trial investigating endogenous modulation and central sensitization in New Daily Persistent Headache (NDPH) in children; results …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Children's Hospital | Conditions: New Daily Persistent Headache (NDPH) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-05-06